Browsing by Subject "Familial hypercholesterolaemia"

Now showing items 1-1 of 1

Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia : the ODYSSEY open-label extension study

Blom, Dirk J.; Breedt, Johannes; Burgess, Lesley J.; Ebrahim, Iftikhar O.; Soma, Prashilla; Van der Walt, Eugene; Naidoo, Poobalan; Van Tonder, Alet; Raal, Frederick J. (Clinics Cardive, 2019-09-21)

BACKGROUND : Alirocumab reduces low-density lipoprotein cholesterol (LDL-C) levels by up to 61%. The ODYSSEY Open-Label Extension study investigated the effect of alirocumab in patients with heterozygous familial ...

Search UPSpace